Form D · Other
Healionics CORP
Seattle, WA · CIK 0001413969
Offering snapshot reported Dec 31, 2025 · SEC filing
- Reported sold
- $1.96M Offering amount: $20M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2025 | Initial | $1,964,221 | No comparison | 30 | SEC filing |
| Feb 20, 2024 | Amendment | $5,519,466 | $2,835,466vs Nov 7, 2023 | 70 | SEC filing |
| Nov 7, 2023 | Initial | $2,684,000 | No comparison | 34 | SEC filing |
| Dec 16, 2020 | Initial | $6,563,649 | No comparison | 86 | SEC filing |
| Jul 31, 2019 | Amendment | $4,198,386 | $385,693vs Feb 22, 2019 | 72 | SEC filing |
| Feb 22, 2019 | Amendment | $3,812,693 | $2,764,625vs Jun 22, 2018 | 66 | SEC filing |
| Jun 22, 2018 | Initial | $1,048,068 | No comparison | 14 | SEC filing |
| Feb 14, 2013 | Initial | $50,000 | No comparison | 1 | SEC filing |
| May 6, 2011 | Amendment | $146,286 | -$50,000vs May 5, 2011 | 7 | SEC filing |
| May 5, 2011 | Initial | $196,286 | No comparison | 7 | SEC filing |
| Apr 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 28, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568585
Source: Form D, filed Dec 31, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michel Alvarez | Director, Executive |
| Mike Connolly | Director, Executive |
| Arthur Coury | Director |
| Art Coury | Director |
| Alan Fuhrman | Director |
| Max Maginness | Executive |
| Andrew Marshall | Director |
| Buddy Ratner | Director |
| Ryan Takeuchi | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2121 N. 35 Th Street, Suite 200
Seattle, WA, 98103
Seattle, WA, 98103